ALLMedicine™ Graves Disease Center
Research & Reviews 261 results
HIV Medicine; Lawal IO, Orunmuyi AT et. al.
Jul 31st, 2021 - We aimed to describe the clinical characteristics and the response to radioactive iodine (RAI) treatment of immune reconstitution inflammatory syndrome-associated Graves disease (IRIS-GD) in comparison to Graves disease (GD) seen in HIV-uninfected...
Neuroimaging Clinics of North America; Debnam JM, Koka K et. al.
Jul 11th, 2021 - Graves disease is an autoimmune disorder caused by the breakdown of immune tolerance to thyroid antigens against the TSH receptor. In approximately 25% of patients, an inflammatory condition, Graves eye disease (GED), affects the orbital soft tiss...
Endocrine Practice : Official Journal of the American Col... Zhu D, Zhang S et. al.
Jul 4th, 2021 - Agranulocytosis is a rare but serious adverse drug reaction (ADR) of thionamide antithyroid drugs (ATDs). We explored the characteristics of ADRs in patients with hyperthyroidism. This retrospective study included 3558 inpatients with Graves disea...
Medicine Besic N, Vidergar-Kralj B et. al.
Jun 24th, 2021 - A hormone-active metastatic Hürthle cell thyroid carcinoma (HCTC) and Graves disease (GD) present a therapeutic challenge and is rarely reported. We present a 64-year-old male patient, who had dyspnea and left hip pain lasting 4 months. He had cli...
Archives of Endocrinology and Metabolism; Saeed MH, Kurosh K et. al.
May 26th, 2021 - Graves' disease (GD) is an autoimmune disease causing the overproduction of the thyroid hormone from thyroid gland. This disease is mainly the result of the production of antibodies against TSH receptors. Cytokines play an important role in orches...
Clinicaltrials.gov 1 results
Jan 10th, 2011 - The extent of thyroid resection in bilateral multinodular non-toxic goiter remains controversial. Surgeons still continue to debate whether the potential benefits of total thyroidectomy outweigh the potential complications. Most low-volume surgeon...
News 39 results
Dec 17th, 2019 - CHICAGO – The investigational monoclonal antibody iscalimab reduced levels of thyroid hormone and thyroid-stimulating hormone–receptor antibodies (TSHR-Ab) in some patients with Graves disease in a small study. Of 15 patients with Graves disease,.
Sirunya Silapunt, MD, Abiara V. Agwu, MD et. al.
Sep 10th, 2019 - To the Editor: A 55-year-old man with a history of Graves disease treated with radioactive iodine and Graves ophthalmopathy was referred to our dermatology clinic by his endocrinologist with a 2-year history of severe pretibial myxedema (PM) that.
Aug 8th, 2019 - Results A total of 329 patients with thyroid nodules were identified: 236 were < 3 cm and 93 were ≥ 3 cm. The 2 groups differed on race, with more white patients in the < 3-cm nodule group (78% vs 67%, P =.
May 3rd, 2019 - Long-term Sequelae Endocrine Thyroid gland abnormalities secondary to DRESS syndrome include Graves disease and Hashimoto disease as well as variations in biomarkers including elevated free thyroxine and low and elevated thyroid-stimulating hormon.
Oct 31st, 2018 - Pearl: DRESS patients need to be monitored for long-term sequelae such as autoimmune disease. Several autoimmune conditions may develop as a delayed complication of DRESS syndrome, including autoimmune thyroiditis, systemic lupus erythematosus, ty.